Short interest for Easton Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Easton Pharmaceuticals's stock. Short interest data is updated every two weeks.

Easton Pharmaceuticals Stock Short Interest Report | OTC:EAPH | Benzinga

EASTON PHARMS INC by Easton Pharmaceuticals, Inc.

Easton Pharmaceuticals

Overview

News

Easton Pharmaceuticals Inc is a diversified specialty pharmaceutical company. It owns and develops proprietary transdermal delivery technology and therapeutic over the counter products and drugs to treat cancer and other diseases. The company also owns exclusive distribution rights in Mexico and Latin America for patented women's diagnostic and preventative care products. It is focused on the development of product Viorra. The firm's products include Nauseasol, Skin Renou HA, Kenestrin gel, and XILIVE, among others.

Comments

Easton Pharmaceuticals Short Interest Report

Easton Pharmaceuticals Stock Short Interest Report | OTC:EAPH | Benzinga